245 related articles for article (PubMed ID: 21039540)
1. Benefits of cocrystallisation in pharmaceutical materials science: an update.
Friščić T; Jones W
J Pharm Pharmacol; 2010 Nov; 62(11):1547-59. PubMed ID: 21039540
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical cocrystals and poorly soluble drugs.
Thakuria R; Delori A; Jones W; Lipert MP; Roy L; Rodríguez-Hornedo N
Int J Pharm; 2013 Aug; 453(1):101-25. PubMed ID: 23207015
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical cocrystals: an overview.
Qiao N; Li M; Schlindwein W; Malek N; Davies A; Trappitt G
Int J Pharm; 2011 Oct; 419(1-2):1-11. PubMed ID: 21827842
[TBL] [Abstract][Full Text] [Related]
4. An investigation of the causes of cocrystal dissociation at high humidity.
Eddleston MD; Thakuria R; Aldous BJ; Jones W
J Pharm Sci; 2014 Sep; 103(9):2859-2864. PubMed ID: 24481664
[TBL] [Abstract][Full Text] [Related]
5. An investigation into the influence of counterion on the properties of some amorphous organic salts.
Towler CS; Li T; Wikström H; Remick DM; Sanchez-Felix MV; Taylor LS
Mol Pharm; 2008; 5(6):946-55. PubMed ID: 19434850
[TBL] [Abstract][Full Text] [Related]
6. The role of cocrystals in pharmaceutical science.
Shan N; Zaworotko MJ
Drug Discov Today; 2008 May; 13(9-10):440-6. PubMed ID: 18468562
[TBL] [Abstract][Full Text] [Related]
7. Ultrasonic determination of Young's moduli of the coat and core materials of a drug tablet.
Akseli I; Becker DC; Cetinkaya C
Int J Pharm; 2009 Mar; 370(1-2):17-25. PubMed ID: 19059326
[TBL] [Abstract][Full Text] [Related]
8. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
Blagden N; de Matas M; Gavan PT; York P
Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
[TBL] [Abstract][Full Text] [Related]
9. Nondestructive and on-line monitoring of tablets using light-induced fluorescence technology.
Lai CK; Zahari A; Miller B; Katstra WE; Cima MJ; Cooney CL
AAPS PharmSciTech; 2004 Jan; 5(1):E3. PubMed ID: 15198524
[TBL] [Abstract][Full Text] [Related]
10. Deliquescence of pharmaceutical systems.
Mauer LJ; Taylor LS
Pharm Dev Technol; 2010 Dec; 15(6):582-94. PubMed ID: 19895256
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging of tablet dissolution.
Nott KP
Eur J Pharm Biopharm; 2010 Jan; 74(1):78-83. PubMed ID: 19602436
[TBL] [Abstract][Full Text] [Related]
12. New forms of old drugs: improving without changing.
Domingos S; André V; Quaresma S; Martins IC; Minas da Piedade MF; Duarte MT
J Pharm Pharmacol; 2015 Jun; 67(6):830-46. PubMed ID: 25648101
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms by which moisture generates cocrystals.
Jayasankar A; Good DJ; Rodríguez-Hornedo N
Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
[TBL] [Abstract][Full Text] [Related]
14. Techniques to assess film coatings and evaluate film-coated products.
Porter SC; Felton LA
Drug Dev Ind Pharm; 2010 Feb; 36(2):128-42. PubMed ID: 20050727
[TBL] [Abstract][Full Text] [Related]
15. Application of on-line Raman spectroscopy for characterizing relationships between drug hydration state and tablet physical stability.
Hausman DS; Cambron RT; Sakr A
Int J Pharm; 2005 Aug; 299(1-2):19-33. PubMed ID: 15979262
[TBL] [Abstract][Full Text] [Related]
16. Multiple-layer compression-coated tablets: formulation and humidity studies of novel chewable amoxicillin/clavulanate tablet formulations.
Wardrop J; Jaber AB; Ayres JW
Drug Dev Ind Pharm; 1998 Aug; 24(8):729-36. PubMed ID: 9876520
[TBL] [Abstract][Full Text] [Related]
17. Cocrystal and its Application in the Field of Active Pharmaceutical Ingredients and Food Ingredients.
Wang N; Xie C; Lu H; Guo N; Lou Y; Su W; Hao H
Curr Pharm Des; 2018; 24(21):2339-2348. PubMed ID: 29788878
[TBL] [Abstract][Full Text] [Related]
18. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of drug physical form during granulation, tabletting and storage.
Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of performance of co crystals of mefloquine hydrochloride in tablet dosage form.
Shete AS; Yadav AV; Murthy MS
Drug Dev Ind Pharm; 2013 May; 39(5):716-23. PubMed ID: 22639963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
